US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.1877
  • -0.0023-1.21%
Close Apr 19 16:00 ET
  • 0.2000
  • +0.0123+6.55%
Post 19:28 ET
47.08MMarket Cap-1706P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-65.62%1.1M
0
0
0
1.1M
9,560.61%3.19M
319,319.22%1.06M
1.06M
1.06M
0
Operating revenue
-65.62%1.1M
--0
--0
--0
--1.1M
9,560.61%3.19M
319,319.22%1.06M
--1.06M
--1.06M
--0
Cost of revenue
Gross profit
Operating expense
-10.50%24.86M
-10.03%5.89M
-5.99%6.13M
-11.86%6.16M
-13.47%6.68M
12.15%27.78M
-2.55%6.54M
-5.13%6.53M
45.90%6.99M
20.91%7.72M
Selling and administrative expenses
-6.55%10.37M
-16.97%2.22M
0.75%2.84M
-9.12%2.6M
-1.17%2.71M
8.98%11.1M
8.15%2.68M
24.87%2.82M
23.91%2.86M
-12.75%2.74M
-General and administrative expense
-6.55%10.37M
-16.97%2.22M
0.75%2.84M
-9.12%2.6M
-1.17%2.71M
8.98%11.1M
8.15%2.68M
24.87%2.82M
23.91%2.86M
-12.75%2.74M
Research and development costs
-13.13%14.49M
-5.22%3.67M
-11.11%3.3M
-13.76%3.56M
-20.25%3.97M
14.37%16.68M
-8.79%3.87M
-19.78%3.71M
66.36%4.13M
53.57%4.98M
Operating profit
3.35%-23.77M
-7.43%-5.89M
-12.30%-6.13M
-3.95%-6.16M
27.66%-5.59M
0.59%-24.59M
18.38%-5.48M
20.59%-5.46M
-23.70%-5.93M
-21.55%-7.72M
Net non-operating interest income expense
Other net income (expense)
-77.07%824K
-68.96%573K
79K
4,850.00%99K
-95.81%73K
147.45%3.59M
12,019.22%1.85M
241.34%2K
24.86%1.74M
Special income (charges)
-86.14%484K
-72.45%484K
--0
--0
--0
162.88%3.49M
373,929.79%1.76M
--0
--0
30.53%1.73M
-Gain on sale of business
-86.14%484K
-72.45%484K
--0
--0
--0
162.88%3.49M
373,929.79%1.76M
--0
--0
30.53%1.73M
Other non- operating income (expenses)
233.33%340K
0.00%89K
--79K
4,850.00%99K
630.00%73K
-17.74%102K
466.81%89K
----
241.34%2K
-85.36%10K
Income before tax
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
-23.62%-5.92M
-20.61%-5.98M
Income tax
Net income
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
-23.62%-5.92M
-20.61%-5.98M
Net income continuous Operations
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
-23.62%-5.92M
-20.61%-5.98M
Minority interest income
Net income attributable to the parent company
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
9.82%-21M
45.75%-3.63M
20.11%-5.46M
-23.62%-5.92M
-20.61%-5.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.26%-22.94M
-46.23%-5.31M
-10.86%-6.06M
-2.31%-6.06M
7.78%-5.51M
11.33%-21M
45.75%-3.63M
20.11%-5.46M
-19.03%-5.92M
-15.69%-5.98M
Basic earnings per share
-10.00%-0.11
-50.00%-0.03
0.00%-0.03
0.00%-0.03
0.00%-0.03
9.09%-0.1
33.33%-0.02
0.00%-0.03
-50.00%-0.03
0.00%-0.03
Diluted earnings per share
-10.00%-0.11
-50.00%-0.03
0.00%-0.03
0.00%-0.03
0.00%-0.03
9.09%-0.1
33.33%-0.02
0.00%-0.03
-50.00%-0.03
0.00%-0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -65.62%1.1M0001.1M9,560.61%3.19M319,319.22%1.06M1.06M1.06M0
Operating revenue -65.62%1.1M--0--0--0--1.1M9,560.61%3.19M319,319.22%1.06M--1.06M--1.06M--0
Cost of revenue
Gross profit
Operating expense -10.50%24.86M-10.03%5.89M-5.99%6.13M-11.86%6.16M-13.47%6.68M12.15%27.78M-2.55%6.54M-5.13%6.53M45.90%6.99M20.91%7.72M
Selling and administrative expenses -6.55%10.37M-16.97%2.22M0.75%2.84M-9.12%2.6M-1.17%2.71M8.98%11.1M8.15%2.68M24.87%2.82M23.91%2.86M-12.75%2.74M
-General and administrative expense -6.55%10.37M-16.97%2.22M0.75%2.84M-9.12%2.6M-1.17%2.71M8.98%11.1M8.15%2.68M24.87%2.82M23.91%2.86M-12.75%2.74M
Research and development costs -13.13%14.49M-5.22%3.67M-11.11%3.3M-13.76%3.56M-20.25%3.97M14.37%16.68M-8.79%3.87M-19.78%3.71M66.36%4.13M53.57%4.98M
Operating profit 3.35%-23.77M-7.43%-5.89M-12.30%-6.13M-3.95%-6.16M27.66%-5.59M0.59%-24.59M18.38%-5.48M20.59%-5.46M-23.70%-5.93M-21.55%-7.72M
Net non-operating interest income expense
Other net income (expense) -77.07%824K-68.96%573K79K4,850.00%99K-95.81%73K147.45%3.59M12,019.22%1.85M241.34%2K24.86%1.74M
Special income (charges) -86.14%484K-72.45%484K--0--0--0162.88%3.49M373,929.79%1.76M--0--030.53%1.73M
-Gain on sale of business -86.14%484K-72.45%484K--0--0--0162.88%3.49M373,929.79%1.76M--0--030.53%1.73M
Other non- operating income (expenses) 233.33%340K0.00%89K--79K4,850.00%99K630.00%73K-17.74%102K466.81%89K----241.34%2K-85.36%10K
Income before tax -9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M-23.62%-5.92M-20.61%-5.98M
Income tax
Net income -9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M-23.62%-5.92M-20.61%-5.98M
Net income continuous Operations -9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M-23.62%-5.92M-20.61%-5.98M
Minority interest income
Net income attributable to the parent company -9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M9.82%-21M45.75%-3.63M20.11%-5.46M-23.62%-5.92M-20.61%-5.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.26%-22.94M-46.23%-5.31M-10.86%-6.06M-2.31%-6.06M7.78%-5.51M11.33%-21M45.75%-3.63M20.11%-5.46M-19.03%-5.92M-15.69%-5.98M
Basic earnings per share -10.00%-0.11-50.00%-0.030.00%-0.030.00%-0.030.00%-0.039.09%-0.133.33%-0.020.00%-0.03-50.00%-0.030.00%-0.03
Diluted earnings per share -10.00%-0.11-50.00%-0.030.00%-0.030.00%-0.030.00%-0.039.09%-0.133.33%-0.020.00%-0.03-50.00%-0.030.00%-0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg